{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:52:32Z","timestamp":1791219152430,"version":"4.1.0"},"reference-count":286,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.3109\/07853899109148056","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T23:24:55Z","timestamp":1208993095000},"page":"241-259","source":"Crossref","is-referenced-by-count":270,"title":["Polyamines: from Molecular Biology to Clinical Applications"],"prefix":"10.1080","volume":"23","author":[{"given":"Juhani","family":"J\u00e4nne","sequence":"first","affiliation":[{"name":"Department of Biochemistry amp; Biotechnology, University of Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Alhonen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry amp; Biotechnology, University of Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Departments of Gynecology and Obstetrics, Helsinki University Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4471-1300-3","volume-title":"Male reproductive function and semen","author":"Mann T","year":"1981","unstructured":"Mann T, Lutwak-Mann C. Male reproductive function and semen. Springer-Verlag, Berlin, Heidelberg, New York 1981; 1\u2013495"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.60.4.1420"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1080533"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.3891\/acta.chem.scand.22-1349"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)14666-X"},{"key":"e_1_2_1_7_1","first-page":"1","volume-title":"Ornithine decarboxylase: Biology, enzymology, and molecular genetics","author":"Hayashi S-I","year":"1989","unstructured":"Ornithine decarboxylase: Biology, enzymology, and molecular genetics, S-I Hayashi. Pergamon Press, New York 1989; 1\u2013147"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.2.540"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.3.731"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.12.3645"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2340249"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)62370-1"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2876518"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2928784"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1987.6.179"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.6.2731"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.6.2359"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)81896-8"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(90)90232-G"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.21.8855"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1.1989.8.623"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)34057-8"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(90)90233-H"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000132266"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000132597"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)45287-8"},{"key":"e_1_2_1_27_1","first-page":"1117","article-title":"Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines","volume":"4","author":"Tonin P N.","year":"1989","unstructured":"Tonin P N., Yeger H, Stallings R L., Srinivasan P R., Lewis W H. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines. Oncogene 1989; 4: 1117\u201321","journal-title":"Oncogene"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-419X(78)90015-X"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)37495-7"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(88)90460-3"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(77)81051-X"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)30047-X"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(76)90033-4"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a122539"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1990.9.103"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(81)90048-2"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)36263-4"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)67685-9"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(86)80892-4"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)61521-2"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38470-4"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38263-8"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.9.12.5484-5490.1989"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.39.070170.004433"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.45.070176.001441"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60911-2"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60422-4"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2290711"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(88)81095-7"},{"key":"e_1_2_1_50_1","article-title":"Production of transgenic mice carrying human and mouse ornithine decarboxylase gene constructs","author":"J\u00e4nne J","year":"1991","unstructured":"J\u00e4nne J, Alhonen L, Halmekyt\u00f6 M, Hyttinen J-M, Sinervirta R, Utriainen M, My\u00f6h\u00e4nen S, Wahlfors J, Kiiskinen M, Voipio H.-M. Production of transgenic mice carrying human and mouse ornithine decarboxylase gene constructs. Life Chemistry reports 1991, (in press)","journal-title":"Life Chemistry reports"},{"key":"e_1_2_1_51_1","first-page":"253","article-title":"The significance of DNA methylation patterns: promoter inhibition by sequence-specific methylation is one functional consequence","volume":"326","author":"Doerfler W","year":"1990","unstructured":"Doerfler W. The significance of DNA methylation patterns: promoter inhibition by sequence-specific methylation is one functional consequence. Philos Trans R Soc Lond [Biol] 1990; 326: 253\u201365","journal-title":"Philos Trans R Soc Lond [Biol]"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.24.10179"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)81280-2"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-152830-0.50003-7"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(90)90193-F"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90430-3"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90431-5"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90330-8"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02991574"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.107.1.165"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)80115-1"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2420205"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.6.2042.2042"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92029-9"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(68)90715-8"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)94408-X"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2430285"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00476a050"},{"key":"e_1_2_1_69_1","first-page":"243","volume-title":"Polyamines in Biology and Medicine","author":"Heby O","year":"1981","unstructured":"Heby O, J\u00e4nne J. Polyamine antimetabolites: Biochemistry, specificity and biological effects of inhibitors of polyamine synthesis. Polyamines in Biology and Medicine, D R. Morris, L J. Marion. Marcel Dekker Inc., New York 1981; 243\u2013310"},{"key":"e_1_2_1_70_1","first-page":"3070","article-title":"Growth-inhibitory effects of DL-alpha-difluoro-methylomithine in the spectrum of human lung carcinoma cells in culture","volume":"42","author":"Luk G D.","year":"1982","unstructured":"Luk G D., Goodwin G, Gazdar A F., Baylin S B. Growth-inhibitory effects of DL-alpha-difluoro-methylomithine in the spectrum of human lung carcinoma cells in culture. Cancer Res. 1982; 42: 3070\u20133","journal-title":"Cancer Res."},{"key":"e_1_2_1_71_1","first-page":"505","article-title":"Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia","volume":"70","author":"Sunkara P S.","year":"1983","unstructured":"Sunkara P S., Prakash N J., Chang C C., Sjoerdsma A. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia. J Natl Cancer Inst 1983; 70: 505\u20139","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_72_1","first-page":"1148","article-title":"Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines","volume":"46","author":"Pera P J.","year":"1986","unstructured":"Pera P J., Kramer D L., Sufrin J R., Porter C W. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res 1986; 46: 1148\u201354","journal-title":"Cancer Res"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/0309-1651(81)90217-4"},{"key":"e_1_2_1_74_1","first-page":"47","article-title":"Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine","volume":"46","author":"Seidenfeld J","year":"1986","unstructured":"Seidenfeld J, Block A L., Komar K A., Naujokas M F. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine. Cancer Res 1986; 46: 47\u201353","journal-title":"Cancer Res"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(83)91642-X"},{"key":"e_1_2_1_76_1","first-page":"335","article-title":"Induction of F9 embryonal carcinomacell differentiation by inhibition of polyamine synthesis","volume":"38","author":"Oredsson S M.","year":"1985","unstructured":"Oredsson S M., Billgren M, Heby O. Induction of F9 embryonal carcinomacell differentiation by inhibition of polyamine synthesis. Eur J Cell Biol 1985; 38: 335\u201343","journal-title":"Eur J Cell Biol"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041220102"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(83)90425-4"},{"key":"e_1_2_1_79_1","first-page":"4067","article-title":"Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylomithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo","volume":"45","author":"Sunkara P S.","year":"1985","unstructured":"Sunkara P S., Chang C C., Prakash N J., Lachmann P J. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylomithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo. Cancer Res 1985; 45: 4067\u201370","journal-title":"Cancer Res"},{"key":"e_1_2_1_80_1","first-page":"1444","article-title":"Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells","volume":"45","author":"K\u00e4pyaho K","year":"1985","unstructured":"K\u00e4pyaho K, Sinervirta R, J\u00e4nne J. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells. Cancer Res 1985; 45: 1444\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V61.4.740.740"},{"key":"e_1_2_1_82_1","first-page":"2812","article-title":"Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells","volume":"43","author":"Chen K Y.","year":"1983","unstructured":"Chen K Y., Nau D, Liu A Y-C. Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells. Cancer Res 1983; 43: 2812\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_83_1","first-page":"1440","article-title":"Effects of polyamine depletion on proliferation and differentation of murine erythro-leukemia cells","volume":"44","author":"Sugiura M","year":"1984","unstructured":"Sugiura M, Shaftman T, Kufe D. Effects of polyamine depletion on proliferation and differentation of murine erythro-leukemia cells. Cancer Res 1984; 44: 1440\u20134","journal-title":"Cancer Res"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.5.1153.1153"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041200302"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(81)91517-5"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1984.246.3.C293"},{"key":"e_1_2_1_88_1","first-page":"59","volume-title":"Ornithine decarboxylase: Biology, enzymology, and molecular genetics","author":"J\u00e4nne J","year":"1989","unstructured":"J\u00e4nne J, Alhonen-Hongisto L. Inhibitors of ornithine decarboxylase: Biochemistry and applications. Ornithine decarboxylase: Biology, enzymology, and molecular genetics, S Hayashi. Pergamon Press, New York 1989; 59\u201385"},{"key":"e_1_2_1_89_1","first-page":"6279","article-title":"Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis-(ethyl)-spermidine, an apparent regulator of the enzyme","volume":"46","author":"Porter C W.","year":"1986","unstructured":"Porter C W., Ganis B, Vinson T, Marton L J., Kramer D L., Bergeron R J. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis-(ethyl)-spermidine, an apparent regulator of the enzyme. Cancer Res 1986; 46: 6279\u201385","journal-title":"Cancer Res"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2420433"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(88)90009-X"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)38070-0"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2680207"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1900747"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1960411"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1982.tb06559.x"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2020519"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1920941"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1042\/bst0100456"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(85)90246-3"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2470651"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2420199"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(87)80485-0"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2580709"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(72)90661-4"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1360669"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(85)90073-1"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1361121"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(84)90014-1"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2310213"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90170-3"},{"key":"e_1_2_1_112_1","first-page":"2246","article-title":"Morphological evidence for an antimitochondria action by methylglyoxal-bis(guanylhydrazone)","volume":"37","author":"Pathak S N.","year":"1977","unstructured":"Pathak S N., Porter C W., Dave C. Morphological evidence for an antimitochondria action by methylglyoxal-bis(guanylhydrazone). Cancer Res 1977; 37: 2246\u20139","journal-title":"Cancer Res"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91406-2"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2280513"},{"key":"e_1_2_1_115_1","first-page":"736","article-title":"Studies on the uptake of methylglyoxal-bis(guanylhydrazone) (CH3-G) and spermidine (Spd) in mouse leukemia sensitive and resistant to CH3-G (L1210\/CH3-G)","volume":"32","author":"Dave C","year":"1973","unstructured":"Dave C, Caballes L. Studies on the uptake of methylglyoxal-bis(guanylhydrazone) (CH3-G) and spermidine (Spd) in mouse leukemia sensitive and resistant to CH3-G (L1210\/CH3-G). Fed Proc 1973; 32: 736","journal-title":"Fed Proc"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.3891\/acta.chem.scand.35b-0731"},{"key":"e_1_2_1_117_1","first-page":"448","article-title":"Use of polyamine antimetabolites in experimental tumors and in human leukemia","volume":"59","author":"J\u00e4nne J","year":"1981","unstructured":"J\u00e4nne J, Alhonen-Hongisto L, Sepp\u00e4nen P, Siimes M. Use of polyamine antimetabolites in experimental tumors and in human leukemia. Med Biol 1981; 59: 448\u201357","journal-title":"Med Biol"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910260508"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(83)90092-2"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2120895"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2180641"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2180947"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1515\/znc-1986-9-1009"},{"key":"e_1_2_1_124_1","first-page":"766","volume-title":"Handbook of Experimental Pharmacology","author":"Mihich E","year":"1975","unstructured":"Mihich E. Bis-guanylhydrazones. Handbook of Experimental Pharmacology. Springer Verlag, New York 1975; vol. 37: 766\u201388"},{"key":"e_1_2_1_125_1","first-page":"303","article-title":"Remarkable differences between the species distributions of various bis(guanylhydrazones) at physiological conditions, and their possible involvement in the strict structural requirements for antileukemic activity","volume":"4","author":"Elo H O.","year":"1989","unstructured":"Elo H O., Tilus P TE, Mutikainen I P., Riekkola M-L. Remarkable differences between the species distributions of various bis(guanylhydrazones) at physiological conditions, and their possible involvement in the strict structural requirements for antileukemic activity. Anti-Cancer Drug Design 1989; 4: 303\u20139","journal-title":"Anti-Cancer Drug Design"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90499-5"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(86)90127-8"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/9.2.199"},{"key":"e_1_2_1_129_1","first-page":"2065","article-title":"Antitumor effect of a new multienzyme inhibitor of polyamine synthetic pathway, methylglyoxal-bis(cyclopentylamidinohydrazone), against human and mouse leukemia cells","volume":"49","author":"Hibasami H","year":"1989","unstructured":"Hibasami H, Maekawa S, Murata T, Nakashima K. Antitumor effect of a new multienzyme inhibitor of polyamine synthetic pathway, methylglyoxal-bis(cyclopentylamidinohydrazone), against human and mouse leukemia cells. Cancer Res 1989; 49: 2065\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2590325"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(79)80988-6"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(85)91844-3"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1989.tb14515.x"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(80)80537-0"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)90102-3"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00263a036"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90066-3"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90292-1"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1159\/000280839"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1159\/000225692"},{"key":"e_1_2_1_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990050408"},{"key":"e_1_2_1_142_1","first-page":"4972","article-title":"Antitumor properties of (2R, 5R)-6-heptyne-2,5-diamine, a new potent enzyme activated irreversible inhibitor of ornithine decarboxylase in rodents","volume":"44","author":"Bartholeyns J","year":"1984","unstructured":"Bartholeyns J, Mamont P, Casara P. Antitumor properties of (2R, 5R)-6-heptyne-2,5-diamine, a new potent enzyme activated irreversible inhibitor of ornithine decarboxylase in rodents. Cancer Res 1984; 44: 4972\u20137","journal-title":"Cancer Res"},{"key":"e_1_2_1_143_1","first-page":"543","article-title":"Treatment of hamster pancreatic cancer with \u03b1-difluoromethylomithine an inhibitor of polyamine biosynthesis","volume":"79","author":"Marx M","year":"1987","unstructured":"Marx M, Townsend C M., Barranco S C., Glass E J., Thompson J C. Treatment of hamster pancreatic cancer with \u03b1-difluoromethylomithine an inhibitor of polyamine biosynthesis. J Natl Cancer Inst 1987; 79: 543\u20138","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990150206"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990150303"},{"key":"e_1_2_1_146_1","first-page":"3529","article-title":"Individual and combined effects of a-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats","volume":"49","author":"Manni A","year":"1989","unstructured":"Manni A, Badger B, Glinkman P, Bartholomew M, Santner S, Demers L. Individual and combined effects of a-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats. Cancer Res 1989; 49: 3529\u201334","journal-title":"Cancer Res"},{"key":"e_1_2_1_147_1","first-page":"5158","article-title":"Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats","volume":"41","author":"Bartholeyns J","year":"1981","unstructured":"Bartholeyns J, Koch-Weser J. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats. Cancer Res 1981; 41: 5158\u201361","journal-title":"Cancer Res"},{"key":"e_1_2_1_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910440622"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910390220"},{"key":"e_1_2_1_150_1","first-page":"933","article-title":"Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis in mice","volume":"47","author":"Sunkara P S.","year":"1987","unstructured":"Sunkara P S., Rosenberger A L. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis in mice. Cancer Res 1987; 47: 933\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_151_1","first-page":"4131","article-title":"Tumor angiogenesis and polyamines: \u03b1-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro","volume":"50","author":"Takigawa M","year":"1990","unstructured":"Takigawa M, Enomoto M, Nishida Y, Pan H-O, Kinshita A, Suzuki F. Tumor angiogenesis and polyamines: \u03b1-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res 1990; 50: 4131\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_152_1","first-page":"1849","article-title":"Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine","volume":"46","author":"Luk G D.","year":"1986","unstructured":"Luk G D., Abeloff M D., McCann P P., Sjoerdsma A, Baylin S B. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine. Cancer Res 1986; 46: 1849\u201353","journal-title":"Cancer Res"},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)33270-2"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(83)90059-X"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5955(90)90143-D"},{"key":"e_1_2_1_156_1","first-page":"153","article-title":"Methylglyoxal-bis(guanylhydrazone), an agent with activity in acute myelotic leukemia and lymphomas","volume":"8","author":"Mihich E","year":"1965","unstructured":"Mihich E. Methylglyoxal-bis(guanylhydrazone), an agent with activity in acute myelotic leukemia and lymphomas. Arch Ital Pat Clin Tumori 1965; 8: 153\u2013206","journal-title":"Arch Ital Pat Clin Tumori"},{"key":"e_1_2_1_157_1","first-page":"360","article-title":"Carcinostatic action of polycarbonyl compounds and their derivatives. II. Glyoxal bis(guanylhydrazone) and derivatives","volume":"18","author":"Freedlander B L.","year":"1958","unstructured":"Freedlander B L., French F A. Carcinostatic action of polycarbonyl compounds and their derivatives. II. Glyoxal bis(guanylhydrazone) and derivatives. Cancer Res 1958; 18: 360\u20133","journal-title":"Cancer Res"},{"key":"e_1_2_1_158_1","first-page":"614","article-title":"Carcinostatic activity of some dicarbonyl compounds and their bishydrazones","volume":"16","author":"French F A.","year":"1960","unstructured":"French F A., Freedlander B L., Hoskins A, French J. Carcinostatic activity of some dicarbonyl compounds and their bishydrazones. Acta Union Int Contra Cancrum 1960; 16: 614\u201324","journal-title":"Acta Union Int Contra Cancrum"},{"key":"e_1_2_1_159_1","first-page":"407","volume-title":"Polyamines in Biology and Medicine","author":"Porter C W.","year":"1981","unstructured":"Porter C W., Dave C, Mihich E. Inhibition of S-adeno-sylmethionine decarboxylase as an approach in cancer therapeutics. Polyamines in Biology and Medicine, D R. Morris, L J. Marton. Marcel Dekker, New York 1981; 407\u201336"},{"key":"e_1_2_1_160_1","first-page":"324","article-title":"Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration","volume":"43","author":"Kallio A","year":"1983","unstructured":"Kallio A, Sepp\u00e4nen P, Alhonen-Hongisto L, J\u00e4nne J. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration. Cancer Res 1983; 43: 324\u20137","journal-title":"Cancer Res"},{"key":"e_1_2_1_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(83)90111-8"},{"key":"e_1_2_1_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(81)90375-5"},{"key":"e_1_2_1_163_1","first-page":"2512","article-title":"Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice","volume":"45","author":"Kramer D L.","year":"1985","unstructured":"Kramer D L., Paul B, Porter C W. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice. Cancer Res 1985; 45: 2512\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910370320"},{"key":"e_1_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1988.tb01619.x"},{"key":"e_1_2_1_166_1","first-page":"196","article-title":"Therapie mit Inhibitoren der Polyaminbiosynthese bein refrakt\u00e4ren Prostatakarzinom","volume":"8","author":"Dunzendorfer U","year":"1985","unstructured":"Dunzendorfer U, Kn\u00f6ner M. Therapie mit Inhibitoren der Polyaminbiosynthese bein refrakt\u00e4ren Prostatakarzinom. Onkologie 1985; 8: 196\u2013200","journal-title":"Onkologie"},{"key":"e_1_2_1_167_1","first-page":"4382","article-title":"Effects of alpha-difluoromethylornithine and methylglyoxal bis-(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice","volume":"44","author":"Herr H W.","year":"1984","unstructured":"Herr H W., Kleinert E L., Conti P S., Burchenal J H., Whitmore W F., Jr. Effects of alpha-difluoromethylornithine and methylglyoxal bis-(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer Res 1984; 44: 4382\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_168_1","first-page":"215","article-title":"The gastrointestinal tract as polyamine source for tumor growth","volume":"9","author":"Sarhan S","year":"1989","unstructured":"Sarhan S, Knodgen B, Seller N. The gastrointestinal tract as polyamine source for tumor growth. Anticancer Res 1989; 9: 215\u201324","journal-title":"Anticancer Res"},{"key":"e_1_2_1_169_1","first-page":"5077","article-title":"Endogenous and exogenous polyamines in support of tumor growth","volume":"50","author":"Seiler N","year":"1990","unstructured":"Seiler N, Sarhan S, Grauffel C, Jones R, Kn\u00f6dgen B, Moulinoux J-P. Endogenous and exogenous polyamines in support of tumor growth. Cancer Res 1990; 50: 5077\u201383","journal-title":"Cancer Res"},{"key":"e_1_2_1_170_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/B978-0-12-481835-4.50014-4","volume-title":"Inhibition of polyamine metabolism: Biological significance and basis for new therapies","author":"Porter C W.","year":"1987","unstructured":"Porter C W., J\u00e4nne J. Modulation of antineoplastic drug action by inhibitors of polyamine biosynthesis. 1987. Inhibition of polyamine metabolism: Biological significance and basis for new therapies, D R. Morris, L J. Marton. Academic Press Inc, New York 1987; 203\u201348"},{"key":"e_1_2_1_171_1","first-page":"3550","article-title":"Effect of alpha-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminechloroplatinum (II), and vinblastine sulfate on the growth of P3J cells in vitro","volume":"46","author":"Allen E D.","year":"1986","unstructured":"Allen E D., Natale R B. Effect of alpha-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminechloroplatinum (II), and vinblastine sulfate on the growth of P3J cells in vitro. Cancer Res 1986; 46: 3550\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_172_1","doi-asserted-by":"publisher","DOI":"10.2307\/3577134"},{"key":"e_1_2_1_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910380117"},{"key":"e_1_2_1_174_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02470650"},{"key":"e_1_2_1_175_1","first-page":"271","article-title":"Inhibition of the growth of pancreatic cancer cell lines by alpha-difluoromethylornithine (DFMO) alone and combined with cis-diaminedihydrochloroplatinum (DDP)","volume":"24","author":"Chang B K.","year":"1983","unstructured":"Chang B K., Black O., Jr. Inhibition of the growth of pancreatic cancer cell lines by alpha-difluoromethylornithine (DFMO) alone and combined with cis-diaminedihydrochloroplatinum (DDP). Proc Am Ass Cancer Res 1983; 24: 271","journal-title":"Proc Am Ass Cancer Res"},{"key":"e_1_2_1_176_1","first-page":"3856","article-title":"Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells","volume":"44","author":"Cavanaugh P F.","year":"1984","unstructured":"Cavanaugh P F., Jr, Pavelic Z P., Porter C W. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells. Cancer Res 1984; 44: 3856\u201361","journal-title":"Cancer Res"},{"key":"e_1_2_1_177_1","first-page":"4426","article-title":"Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor","volume":"41","author":"Marton L J.","year":"1981","unstructured":"Marton L J., Levin V A., Hervatin S J., Koch-Weser J, McCann P P., Sjoerdsma A. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 1981; 41: 4426\u201331","journal-title":"Cancer Res"},{"key":"e_1_2_1_178_1","first-page":"2132","article-title":"Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion","volume":"45","author":"Seidenfeld J","year":"1985","unstructured":"Seidenfeld J, Komar K A. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion. Cancer Res 1985; 45: 2132\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_179_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910350620"},{"key":"e_1_2_1_180_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6186025"},{"key":"e_1_2_1_181_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910370117"},{"key":"e_1_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(87)80279-6"},{"key":"e_1_2_1_183_1","first-page":"39","article-title":"Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro","volume":"44","author":"Alhonen-Hongisto L","year":"1984","unstructured":"Alhonen-Hongisto L, Deen D F., Marton L J. Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro. Cancer Res 1984; 44: 39\u201342","journal-title":"Cancer Res"},{"key":"e_1_2_1_184_1","first-page":"4440","article-title":"Decreased cell kill of vincristine and methotrexate againts 9L rat brain tumorcells in vitro caused by alpha-difluoromethylor-nithine-induced polyamine depletion","volume":"44","author":"Alhonen-Hongisto L","year":"1984","unstructured":"Alhonen-Hongisto L, Hung D T., Deen D F., Marton L J. Decreased cell kill of vincristine and methotrexate againts 9L rat brain tumorcells in vitro caused by alpha-difluoromethylor-nithine-induced polyamine depletion. Cancer Res 1984; 44: 4440\u20132","journal-title":"Cancer Res"},{"key":"e_1_2_1_185_1","first-page":"1296","article-title":"Decreased cytotoxicity of cis-diamminedichloro-platinum (II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumorcells in vitro","volume":"42","author":"Oredsson S M.","year":"1982","unstructured":"Oredsson S M., Deen D F., Marton L J. Decreased cytotoxicity of cis-diamminedichloro-platinum (II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumorcells in vitro. Cancer Res 1982; 42: 1296\u20139","journal-title":"Cancer Res"},{"key":"e_1_2_1_186_1","first-page":"2541","article-title":"Decreased cytotoxicity of 1-beta-D-arabino-furanosylcytosine in 9L rat brain tumorcells pretreated with alpha-difluoromethylornithine in vitro","volume":"43","author":"Oredsson S M.","year":"1983","unstructured":"Oredsson S M., Gray J W., Deen D F., Marton L J. Decreased cytotoxicity of 1-beta-D-arabino-furanosylcytosine in 9L rat brain tumorcells pretreated with alpha-difluoromethylornithine in vitro. Cancer Res 1983; 43: 2541\u20134","journal-title":"Cancer Res"},{"key":"e_1_2_1_187_1","first-page":"1155","article-title":"Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment","volume":"46","author":"Seidenfeld J","year":"1986","unstructured":"Seidenfeld J, Komar K A., Naujokas M F., Block A L. Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment. Cancer Res 1986; 46: 1155\u20139","journal-title":"Cancer Res"},{"key":"e_1_2_1_188_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00299860"},{"key":"e_1_2_1_189_1","first-page":"2247","article-title":"Schedule-dependent interaction of alpha-difluoromethylornithine and cis-diamminedichloroplatinum (II) against human and hamster pancreatic cancer cell lines","volume":"47","author":"Chang B K.","year":"1987","unstructured":"Chang B K., Gutman R, Chou T-C. Schedule-dependent interaction of alpha-difluoromethylornithine and cis-diamminedichloroplatinum (II) against human and hamster pancreatic cancer cell lines. Cancer Res 1987; 47: 2247\u201350","journal-title":"Cancer Res"},{"key":"e_1_2_1_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60265-1"},{"key":"e_1_2_1_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(82)91065-8"},{"key":"e_1_2_1_192_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.19.6028"},{"key":"e_1_2_1_193_1","first-page":"3732","article-title":"Inhibition of mouse skin tumor promotion and of promoter-stimulatd epidermal polyamine biosynthesis by alpha-difluoromethylornithine","volume":"43","author":"Takigawa M","year":"1983","unstructured":"Takigawa M, Verma A K., Simsiman R C., Boutwell R K. Inhibition of mouse skin tumor promotion and of promoter-stimulatd epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Cancer Res 1983; 43: 3732\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_194_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/5.12.1649"},{"key":"e_1_2_1_195_1","first-page":"1170","article-title":"Effect of concentration of D,L-2-difluoromethylornithine on murine mammary carcinogenesis","volume":"45","author":"Thompson H J.","year":"1985","unstructured":"Thompson H J., Meeker L D., Herbst E J., Ronan A M., Minocha R. Effect of concentration of D,L-2-difluoromethylornithine on murine mammary carcinogenesis. Cancer Res 1985; 45: 1170\u20133","journal-title":"Cancer Res"},{"key":"e_1_2_1_196_1","first-page":"2545","article-title":"Inhibition of ornithine decarboxylase with 2-difiuoromethylomithine: reduced incidence of dimet-hylhydrazine-induced colon tumors in mice","volume":"43","author":"Kingsnorth A N.","year":"1983","unstructured":"Kingsnorth A N., King W WK, Diekema K A., McCann P P., Ross J S., Malt R A. Inhibition of ornithine decarboxylase with 2-difiuoromethylomithine: reduced incidence of dimet-hylhydrazine-induced colon tumors in mice. Cancer Res 1983; 43: 2545\u20139","journal-title":"Cancer Res"},{"key":"e_1_2_1_197_1","first-page":"2562","article-title":"Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-a-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet","volume":"50","author":"Reddy B S.","year":"1990","unstructured":"Reddy B S., Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-a-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 1990; 50: 2562\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_198_1","first-page":"648","article-title":"Inhibition of carcinogenesis by alpha-difluoromethylornithine in heterotopically transplanted rat urinary bladders","volume":"45","author":"Homma Y","year":"1985","unstructured":"Homma Y, Ozono S, Numata I, Seidenfeld J, Oyasu R. Inhibition of carcinogenesis by alpha-difluoromethylornithine in heterotopically transplanted rat urinary bladders. Cancer Res 1985; 45: 648\u201352","journal-title":"Cancer Res"},{"key":"e_1_2_1_199_1","first-page":"257","article-title":"Prevention of inhibition effects of alpha-difluoromethylornithine on rat urinary bladder carcinogenesis by exogenous putrescine","volume":"8","author":"Nowels K","year":"1986","unstructured":"Nowels K, Homma Y, Seidenfeld J, Oyasu R. Prevention of inhibition effects of alpha-difluoromethylornithine on rat urinary bladder carcinogenesis by exogenous putrescine. Cancer Biochem Biophys 1986; 8: 257\u201363","journal-title":"Cancer Biochem Biophys"},{"key":"e_1_2_1_200_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.150"},{"key":"e_1_2_1_201_1","first-page":"843","article-title":"Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer","volume":"70","author":"Abeloff M D.","year":"1986","unstructured":"Abeloff M D., Rosen S T., Luk G D., Baylin S B., Zeltman M, Sjoerdsma A. Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat Rep 1986; 70: 843\u20135","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_202_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00179433"},{"key":"e_1_2_1_203_1","first-page":"890","article-title":"Decarboxyiated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by alpha-difluoromethylornithine","volume":"47","author":"Haegele K D.","year":"1987","unstructured":"Haegele K D., Splinter T AW, Romijn J C., Schechter P J., Sjoerdsma A. Decarboxyiated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by alpha-difluoromethylornithine. Cancer Res 1987; 47: 890\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_204_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890201)63:3<433::AID-CNCR2820630306>3.0.CO;2-5"},{"key":"e_1_2_1_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435834"},{"key":"e_1_2_1_206_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910280506"},{"key":"e_1_2_1_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(86)90343-3"},{"key":"e_1_2_1_208_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00254263"},{"key":"e_1_2_1_209_1","first-page":"43","article-title":"Preliminary clinical results of the combination of methylglyoxal guanylhydrazone (M.GAG) and difluoromethylornithine (DFMO)","volume":"2","author":"Auclerc M-F","year":"1983","unstructured":"Auclerc M-F, Weil M, Jacquillat C I. Preliminary clinical results of the combination of methylglyoxal guanylhydrazone (M.GAG) and difluoromethylornithine (DFMO). Proc Am Soc Clin Oncol 1983; 2: 43","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_210_1","first-page":"1367","article-title":"Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: Phase I evaluation of alpha-difluoromethylornithine and bis(guanylhydrazone) treatment of human hematological malignancies","volume":"48","author":"Maddox A-M","year":"1988","unstructured":"Maddox A-M, Freireich E J., Keating M J., Haddox M K. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: Phase I evaluation of alpha-difluoromethylornithine and bis(guanylhydrazone) treatment of human hematological malignancies. Cancer Res 1988; 48: 1367\u201373","journal-title":"Cancer Res"},{"key":"e_1_2_1_211_1","doi-asserted-by":"publisher","DOI":"10.1159\/000238602"},{"key":"e_1_2_1_212_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00170848"},{"key":"e_1_2_1_213_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262590"},{"key":"e_1_2_1_214_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841201)54:2 <2702::AID-CNCR2820541416>3.0.CO;2-#"},{"key":"e_1_2_1_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)31014-4"},{"key":"e_1_2_1_216_1","first-page":"459","article-title":"Phase I\u2013II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors","volume":"71","author":"Levin V A.","year":"1987","unstructured":"Levin V A., Chamberlain M C., Prados M D., Choucair A K., Berger M S., Silver P, Seager M, Gutin P H., Davis R L., Wilson C B. Phase I\u2013II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors. Cancer Treat Rev 1987; 71: 459\u201364","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_217_1","first-page":"459","article-title":"Penetration of methylglyoxal bis(guanyl-hydrazone) into intracerebral tumors in humans","volume":"41","author":"Rosenblum M G.","year":"1981","unstructured":"Rosenblum M G., Stewart D J., Yap B S., Leavens M, Benjamin R S., Loo T L. Penetration of methylglyoxal bis(guanyl-hydrazone) into intracerebral tumors in humans. Cancer Res 1981; 41: 459\u201362","journal-title":"Cancer Res"},{"key":"e_1_2_1_218_1","first-page":"2799","article-title":"Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylomithine by interferon inducers","volume":"44","author":"Sunkara P S.","year":"1984","unstructured":"Sunkara P S., Prakash N J., Rosenberger A L., Hagan A C., Lachmann P J., Mayer G G. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylomithine by interferon inducers. Cancer Res 1984; 44: 2799\u2013802","journal-title":"Cancer Res"},{"key":"e_1_2_1_219_1","first-page":"3220","article-title":"Effects of alpha-difluoromethylornithine and recombinant in-terferon-alpha2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice","volume":"44","author":"Heston W DW","year":"1984","unstructured":"Heston W DW, Fleischmann J, Tackett R E., Ratliff T L. Effects of alpha-difluoromethylornithine and recombinant in-terferon-alpha2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Cancer Res 1984; 44: 3220\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_220_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(86)90166-5"},{"key":"e_1_2_1_221_1","first-page":"183","article-title":"Methylglyoxal bis(guanyl-hydrazone): a new agent active against acute myelocytic leukemia","volume":"16","author":"Freireich E J.","year":"1962","unstructured":"Freireich E J., Frei I E., II, Karon M. Methylglyoxal bis(guanyl-hydrazone): a new agent active against acute myelocytic leukemia. Cancer Chemother Rep 1962; 16: 183\u20136","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_222_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V21.6.689.689"},{"key":"e_1_2_1_223_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt19656131"},{"key":"e_1_2_1_224_1","first-page":"227","volume-title":"Special Topics in Endocrinology and Metabolism","author":"J\u00e4nne J","year":"1983","unstructured":"J\u00e4nne J, H\u00f6ltt\u00e4 E, Kallio A, K\u00e4pyaho K. Role of polyamines and their antimetabolites in clinical medicine. Special Topics in Endocrinology and Metabolism, M P. Cohen, P P. Foa. Alan R Liss Inc, New York 1983; vol 5: 227\u201393"},{"key":"e_1_2_1_225_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.1.52"},{"key":"e_1_2_1_226_1","first-page":"135","article-title":"Mitoguazon (Methylglyoxal-bis guanylhydrazon): Stand und Perspektiven","volume":"59","author":"Hoffmann H","year":"1989","unstructured":"Hoffmann H, Gutsche W, Amlacher R, Schulze W, Werner W, Lenk H, Wohlrab W, Haupt E. Mitoguazon (Methylglyoxal-bis guanylhydrazon): Stand und Perspektiven. Arch Geschwulstforsch 1989; 59: 135\u201348","journal-title":"Arch Geschwulstforsch"},{"key":"e_1_2_1_227_1","first-page":"1375","article-title":"Current studies with methylglyoxal bis(guanyl-hydrazone)","volume":"23","author":"Mihich E","year":"1963","unstructured":"Mihich E. Current studies with methylglyoxal bis(guanyl-hydrazone). Cancer Res 1963; 23: 1375\u201389","journal-title":"Cancer Res"},{"key":"e_1_2_1_228_1","first-page":"81","article-title":"Initial clinical study of parenteral methylglyoxal bis(guanylhydrazone) diacetate","volume":"11","author":"Regelson W","year":"1961","unstructured":"Regelson W, Holland J F. Initial clinical study of parenteral methylglyoxal bis(guanylhydrazone) diacetate. Cancer Chemother Rev 1961; 11: 81\u20136","journal-title":"Cancer Chemother Rev"},{"key":"e_1_2_1_229_1","first-page":"689","article-title":"Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly","volume":"58","author":"Shnider B I.","year":"1974","unstructured":"Shnider B I., Colsky J, Jones R, Carbone P P. Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly. Cancer Chemother Rev 1974; 58: 689\u201395","journal-title":"Cancer Chemother Rev"},{"key":"e_1_2_1_230_1","first-page":"1933","article-title":"Phase I\u2013II trial of methyl-GAG: A Southwest oncology group pilot study","volume":"63","author":"Knight I WA","year":"1979","unstructured":"Knight I WA, II, Livingston R B., Fabian C, Costanzi J. Phase I\u2013II trial of methyl-GAG: A Southwest oncology group pilot study. Cancer Treat Rev 1979; 63: 1933\u20137","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_231_1","first-page":"561","article-title":"Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung","volume":"68","author":"Scher H","year":"1984","unstructured":"Scher H, Chapman R, Kelsen D, Gralla R, Wittes R. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung. Cancer Treat Rev 1984; 68: 561\u20132","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_232_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198412000-00025"},{"key":"e_1_2_1_233_1","first-page":"461","article-title":"Phase II trial of mitoguazone in patients with refractory germ cell tumors","volume":"69","author":"Chun H","unstructured":"Chun H, Bosl G J. Phase II trial of mitoguazone in patients with refractory germ cell tumors. Cancer Treat Rev, 69: 461\u20132","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_234_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198508000-00008"},{"key":"e_1_2_1_235_1","first-page":"1301","article-title":"Phase II trial of mitoguazone in patients with advanced head and neck cancer","volume":"68","author":"Thongprasert B","year":"1984","unstructured":"Thongprasert B, Bosl G J., Geller N L., Wittes R E. Phase II trial of mitoguazone in patients with advanced head and neck cancer. Cancer Treat Rep 1984; 68: 1301\u20132","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_236_1","first-page":"531","article-title":"Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study","volume":"70","author":"Inamasu M S.","year":"1986","unstructured":"Inamasu M S., Oishi N, Chen T T., Kraut E H., Grozea P N., Constanzi J J., Bonnet J D. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study. Cancer Treat Rev 1986; 70: 531\u20132","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_237_1","first-page":"89","article-title":"Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern cancer study group trial","volume":"71","author":"Moore M R.","year":"1987","unstructured":"Moore M R., Graham S D., Birch R, Irwin L. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern cancer study group trial. Cancer Treat Rev 1987; 71: 89\u201390","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_238_1","first-page":"291","article-title":"Salvage treatment of unfavourable non-Hondgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study","volume":"70","author":"Dana B W.","year":"1986","unstructured":"Dana B W., Jones S E., Coltman C, Stuckey W J. Salvage treatment of unfavourable non-Hondgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study. Cancer Treat Rev 1986; 70: 291\u20132","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_239_1","first-page":"47","article-title":"Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide","volume":"71","author":"Warrell R P.","year":"1987","unstructured":"Warrell R P., Danieu L, Coonley C J., Atkins C. Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide. Cancer Treat Rev 1987; 71: 47\u201351","journal-title":"Cancer Treat Rev"},{"key":"e_1_2_1_240_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.3.407"},{"key":"e_1_2_1_241_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.4.556"},{"key":"e_1_2_1_242_1","first-page":"47","article-title":"Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease","volume":"25","author":"Cabanillas F","year":"1988","unstructured":"Cabanillas F, Velasquez W S., McLaughin P, Jagannath S, Hagemeister F B., Redman J R., Swan F, Rodriquez M A. Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease. Semin Hematol 1988; 25: 47\u201350","journal-title":"Semin Hematol"},{"key":"e_1_2_1_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(82)90129-2"},{"key":"e_1_2_1_244_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12558288"},{"key":"e_1_2_1_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(79)90069-3"},{"key":"e_1_2_1_246_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00510092"},{"key":"e_1_2_1_247_1","first-page":"1580","article-title":"Acute and chronic ultraviolet radiation induction of epidermal ornithine decarboxylase activity in hairless mice","volume":"50","author":"Hillebrand G G.","year":"1990","unstructured":"Hillebrand G G., Winslow M S., Benzinger M J., Heitmeyer D A., Bissett D L. Acute and chronic ultraviolet radiation induction of epidermal ornithine decarboxylase activity in hairless mice. Cancer Res 1990; 50: 1580\u20134","journal-title":"Cancer Res"},{"key":"e_1_2_1_248_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12542177"},{"key":"e_1_2_1_249_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640310092029"},{"key":"e_1_2_1_250_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12277319"},{"key":"e_1_2_1_251_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199004000-00015"},{"key":"e_1_2_1_252_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12507519"},{"key":"e_1_2_1_253_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1982.tb00384.x"},{"key":"e_1_2_1_254_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb06602.x"},{"key":"e_1_2_1_255_1","first-page":"17","article-title":"Experimental approaches to the systemic and topical use of polyamine antimetabolites as antiproliferative agents","volume":"4","author":"J\u00e4nne","year":"1983","unstructured":"J\u00e4nne, Alhonen J., Hongisto L, K\u00e4pyaho K, Sepp\u00e4nen P. Experimental approaches to the systemic and topical use of polyamine antimetabolites as antiproliferative agents. Adv Polyamine Res 1983; 4: 17\u201332","journal-title":"Adv Polyamine Res"},{"key":"e_1_2_1_256_1","first-page":"377","article-title":"Les polyamines dans le psoriasis","volume":"107","author":"Grosshans E","year":"1980","unstructured":"Grosshans E, Henry M, Tell G, Schechter P, B\u00f6hlen P, Grove J, Koch-Weser J. Les polyamines dans le psoriasis. Ann Dermatol Venereol (Paris) 1980; 107: 377\u201387","journal-title":"Ann Dermatol Venereol (Paris)"},{"key":"e_1_2_1_257_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb00996.x"},{"key":"e_1_2_1_258_1","doi-asserted-by":"publisher","DOI":"10.2340\/0001555562221224"},{"key":"e_1_2_1_259_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.4.403"},{"key":"e_1_2_1_260_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6775372"},{"key":"e_1_2_1_261_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1981.tb02798.x"},{"key":"e_1_2_1_262_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90270-7"},{"key":"e_1_2_1_263_1","first-page":"161","article-title":"Curative effect of alpha-difluoromethylornithine on fatal Trypanosoma congolence infection in mice","volume":"33","author":"Karbe E","year":"1982","unstructured":"Karbe E, B\u00f6ttger M, McCann P P., Sjoerdsma A, Freites E K. Curative effect of alpha-difluoromethylornithine on fatal Trypanosoma congolence infection in mice. Tropenmed Parasit 1982; 33: 161\u20132","journal-title":"Tropenmed Parasit"},{"key":"e_1_2_1_264_1","first-page":"221","article-title":"Antagonism of polyamine metabolism\u2013a critical factor in chemotherapy of African Trypanosomiasis","volume":"4","author":"Bacchi C J.","year":"1983","unstructured":"Bacchi C J., McCann P P., Nathan H C., Hutner S H., Sjoerdsma A. Antagonism of polyamine metabolism\u2013a critical factor in chemotherapy of African Trypanosomiasis. Adv Polyamine Res 1983; 4: 221\u201331","journal-title":"Adv Polyamine Res"},{"key":"e_1_2_1_265_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90144-7"},{"key":"e_1_2_1_266_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(83)90022-1"},{"key":"e_1_2_1_267_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.8.1485"},{"key":"e_1_2_1_268_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1986.tb05599.x"},{"key":"e_1_2_1_269_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.33"},{"key":"e_1_2_1_270_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1982.tb05418.x"},{"key":"e_1_2_1_271_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47475-3"},{"key":"e_1_2_1_272_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38472-8"},{"key":"e_1_2_1_273_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(86)90087-6"},{"key":"e_1_2_1_274_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)21222-8"},{"key":"e_1_2_1_275_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2420221"},{"key":"e_1_2_1_276_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00531084"},{"key":"e_1_2_1_277_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.651"},{"key":"e_1_2_1_278_1","first-page":"613","article-title":"Pneumocystis carinii pheumonia treated with alpha-difluoromethylornithine","volume":"141","author":"Golden J A.","year":"1984","unstructured":"Golden J A., Schoerdsma A, Santi D V. Pneumocystis carinii pheumonia treated with alpha-difluoromethylornithine. West J Med 1984; 141: 613\u201323","journal-title":"West J Med"},{"key":"e_1_2_1_279_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380160055013"},{"key":"e_1_2_1_280_1","first-page":"436P","article-title":"Inhibition of early embryogenic development in mice by alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of L-ornithine decarboxylase","volume":"66","author":"Fozard J R.","year":"1979","unstructured":"Fozard J R., Grove J, Part M L., Prakash N J. Inhibition of early embryogenic development in mice by alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of L-ornithine decarboxylase. Br J Pharmacol 1979; 66: 436P\u20137P","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_281_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6768132"},{"key":"e_1_2_1_282_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90342-8"},{"key":"e_1_2_1_283_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(81)90094-9"},{"key":"e_1_2_1_284_1","first-page":"141","article-title":"Immunosuppressive effect of (2R, 5R)-6-heptyne-2,5-diamine an inhibitor of polyamine biosynthesis: I: Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes","volume":"72","author":"Pasquali J-L","year":"1988","unstructured":"Pasquali J-L, Mamont P S., Weryha A, Knapp A-M, Blervaque A, Siat M. Immunosuppressive effect of (2R, 5R)-6-heptyne-2,5-diamine an inhibitor of polyamine biosynthesis: I: Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes. Clin Exp Immunol 1988; 72: 141\u20134","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_285_1","first-page":"293","article-title":"Immunosuppressive effects of 2,5-diamine, an inhibitor of polyamine synthesis. II. Beneficial effects on the development of a lupus-like disease in MRL-1pr\/1pr mice","volume":"72","author":"Claverie N","year":"1988","unstructured":"Claverie N, Pasquali J-L, Mamont P S., Danzin C, Weil-Bousson M, Siat M. Immunosuppressive effects of 2,5-diamine, an inhibitor of polyamine synthesis. II. Beneficial effects on the development of a lupus-like disease in MRL-1pr\/1pr mice. Clin Exp Immunol 1988; 72: 293\u20138","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_286_1","first-page":"239","article-title":"Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-1 pr\/1 pr mice","volume":"78","author":"Thomas T J.","year":"1989","unstructured":"Thomas T J., Messner R P. Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-1 pr\/1 pr mice. Clin Exp Immunol 1989; 78: 239\u201344","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_287_1","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90102-W"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/07853899109148056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:40:42Z","timestamp":1770918042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/07853899109148056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":286,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["10.3109\/07853899109148056"],"URL":"https:\/\/doi.org\/10.3109\/07853899109148056","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}